• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于管理耐碳青霉烯类细菌的无抗生素化合物;一篇叙述性综述。

Antibiotics-free compounds for managing carbapenem-resistant bacteria; a narrative review.

作者信息

Shariati Aref, Kashi Milad, Chegini Zahra, Hosseini Seyed Mostafa

机构信息

Infectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.

Student research committee, Arak University of Medical Sciences, Arak, Iran.

出版信息

Front Pharmacol. 2024 Sep 17;15:1467086. doi: 10.3389/fphar.2024.1467086. eCollection 2024.

DOI:10.3389/fphar.2024.1467086
PMID:39355778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11442292/
Abstract

Carbapenem-resistant (CR) Gram-negative bacteria have become a significant public health problem in the last decade. In recent years, the prevalence of CR bacteria has increased. The resistance to carbapenems could result from different mechanisms such as loss of porin, penicillin-binding protein alteration, carbapenemase, efflux pump, and biofilm community. Additionally, genetic variations like insertion, deletion, mutation, and post-transcriptional modification of corresponding coding genes could decrease the susceptibility of bacteria to carbapenems. In this regard, scientists are looking for new approaches to inhibit CR bacteria. Using bacteriophages, natural products, nanoparticles, disulfiram, N-acetylcysteine, and antimicrobial peptides showed promising inhibitory effects against CR bacteria. Additionally, the mentioned compounds could destroy the biofilm community of CR bacteria. Using them in combination with conventional antibiotics increases the efficacy of antibiotics, decreases their dosage and toxicity, and resensitizes CR bacteria to antibiotics. Therefore, in the present review article, we have discussed different aspects of non-antibiotic approaches for managing and inhibiting the CR bacteria and various methods and procedures used as an alternative for carbapenems against these bacteria.

摘要

耐碳青霉烯革兰氏阴性菌在过去十年中已成为一个重大的公共卫生问题。近年来,耐碳青霉烯细菌的流行率有所上升。对碳青霉烯类药物的耐药性可能由不同机制引起,如孔蛋白丢失、青霉素结合蛋白改变、碳青霉烯酶、外排泵和生物膜群落。此外,相应编码基因的插入、缺失、突变和转录后修饰等基因变异可能会降低细菌对碳青霉烯类药物的敏感性。在这方面,科学家们正在寻找抑制耐碳青霉烯细菌的新方法。使用噬菌体、天然产物、纳米颗粒、双硫仑、N-乙酰半胱氨酸和抗菌肽对耐碳青霉烯细菌显示出有前景的抑制作用。此外,上述化合物可以破坏耐碳青霉烯细菌的生物膜群落。将它们与传统抗生素联合使用可提高抗生素的疗效,降低其剂量和毒性,并使耐碳青霉烯细菌重新对抗生素敏感。因此,在本综述文章中,我们讨论了管理和抑制耐碳青霉烯细菌的非抗生素方法的不同方面,以及用作碳青霉烯类药物替代物对抗这些细菌的各种方法和程序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d72/11442292/8d5b19c926a1/fphar-15-1467086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d72/11442292/8d5b19c926a1/fphar-15-1467086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d72/11442292/8d5b19c926a1/fphar-15-1467086-g001.jpg

相似文献

1
Antibiotics-free compounds for managing carbapenem-resistant bacteria; a narrative review.用于管理耐碳青霉烯类细菌的无抗生素化合物;一篇叙述性综述。
Front Pharmacol. 2024 Sep 17;15:1467086. doi: 10.3389/fphar.2024.1467086. eCollection 2024.
2
Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy.全球碳青霉烯类耐药肠杆菌科的传播:流行病学特征、耐药机制、检测和治疗。
Microbiol Res. 2023 Jan;266:127249. doi: 10.1016/j.micres.2022.127249. Epub 2022 Nov 4.
3
A method to quantify viable carbapenem resistant gram-negative bacteria in treated and untreated wastewater.一种定量处理和未处理废水中耐碳青霉烯革兰氏阴性菌活菌的方法。
J Microbiol Methods. 2020 Dec;179:106070. doi: 10.1016/j.mimet.2020.106070. Epub 2020 Oct 2.
4
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.全球碳青霉烯类耐药革兰氏阴性菌的威胁
Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022.
5
Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.新出现的抗生素耐药性:产碳青霉烯酶肠杆菌。新的有害病菌,却仍无新药。
Infez Med. 2019 Dec 1;27(4):357-364.
6
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies.碳青霉烯类耐药革兰阴性菌感染成人的全因死亡率:针对病原体的前瞻性、随机、干预性临床研究的综合综述
Expert Rev Anti Infect Ther. 2022 May;20(5):707-719. doi: 10.1080/14787210.2022.2020099. Epub 2022 Jan 12.
7
The use of combination therapy for the improvement of colistin activity against bacterial biofilm.联合治疗提高黏菌素对细菌生物膜活性的应用。
Braz J Microbiol. 2024 Mar;55(1):411-427. doi: 10.1007/s42770-023-01189-7. Epub 2023 Nov 30.
8
Susceptibility of cefiderocol and other antibiotics against carbapenem-resistant, Gram-negative bacteria.头孢地尔及其他抗生素对碳青霉烯耐药革兰阴性菌的敏感性
Ann Transl Med. 2022 Mar;10(5):261. doi: 10.21037/atm-22-889.
9
Diversity and Genetic Basis for Carbapenem Resistance in a Coastal Marine Environment.沿海海洋环境中碳青霉烯类耐药性的多样性和遗传基础。
Appl Environ Microbiol. 2020 May 5;86(10). doi: 10.1128/AEM.02939-19.
10
Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant .非碳青霉烯酶产生碳青霉烯耐药肠杆菌科细菌的碳青霉烯耐药机制研究。
Front Cell Infect Microbiol. 2024 Sep 18;14:1464816. doi: 10.3389/fcimb.2024.1464816. eCollection 2024.

引用本文的文献

1
Natural compounds for colistin-resistant Acinetobacter baumannii biofilm control: eugenol, cinnamaldehyde, and carvacrol.用于控制耐黏菌素鲍曼不动杆菌生物膜的天然化合物:丁香酚、肉桂醛和香芹酚。
Mol Biol Rep. 2025 Jul 18;52(1):735. doi: 10.1007/s11033-025-10844-1.
2
Influence of N-Acetyl-L-Cysteine on the Pharmacokinetics and Antibacterial Activity of Marbofloxacin in Chickens.N-乙酰-L-半胱氨酸对鸡体内马波沙星药代动力学及抗菌活性的影响
Antibiotics (Basel). 2025 Apr 10;14(4):393. doi: 10.3390/antibiotics14040393.

本文引用的文献

1
A Nonbactericidal Anionic Antimicrobial Peptide Provides Prophylactic and Therapeutic Efficacies against Bacterial Infections in Mice by Immunomodulatory-Antithrombotic Duality.一种非杀菌性阴离子抗菌肽通过免疫调节-抗血栓双重作用为小鼠的细菌感染提供预防和治疗功效。
J Med Chem. 2024 May 9;67(9):7487-7503. doi: 10.1021/acs.jmedchem.4c00342. Epub 2024 Apr 30.
2
Cathelicidin AS-12W Derived from the Alligator sinensis and Its Antimicrobial Activity Against Drug-Resistant Gram-Negative Bacteria In Vitro and In Vivo.源自扬子鳄的抗菌肽AS-12W及其对耐药革兰氏阴性菌的体外和体内抗菌活性
Probiotics Antimicrob Proteins. 2024 Apr 8. doi: 10.1007/s12602-024-10250-2.
3
Efficacy of the bee-venom antimicrobial peptide Osmin against sensitive and carbapenem-resistant Klebsiella pneumoniae strains.
蜂毒液抗菌肽 Osmin 对敏感和碳青霉烯类耐药肺炎克雷伯菌的疗效。
Int J Antimicrob Agents. 2024 Feb;63(2):107054. doi: 10.1016/j.ijantimicag.2023.107054. Epub 2023 Dec 10.
4
Acetylcysteine increases sensitivity of ceftazidime-avibactam-resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo.乙酰半胱氨酸增加了不同酶耐药性的头孢他啶-阿维巴坦耐药肠杆菌科对头孢他啶-阿维巴坦的体外和体内敏感性。
BMC Microbiol. 2023 Nov 3;23(1):321. doi: 10.1186/s12866-023-03068-5.
5
BamA-targeted antimicrobial peptide design for enhanced efficacy and reduced toxicity.靶向 BamA 的抗菌肽设计以提高疗效和降低毒性。
Amino Acids. 2023 Oct;55(10):1317-1331. doi: 10.1007/s00726-023-03307-z. Epub 2023 Sep 5.
6
Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram.使用双硫仑使耐碳青霉烯类和多黏菌素的多重耐药革兰氏阴性菌重新敏感化。
Commun Biol. 2023 Aug 3;6(1):810. doi: 10.1038/s42003-023-05173-7.
7
Rationale and evidence for the adjunctive use of N-acetylcysteine in multidrug-resistant infections.辅助使用 N-乙酰半胱氨酸治疗多重耐药感染的原理和依据。
Eur Rev Med Pharmacol Sci. 2023 May;27(9):4316-4325. doi: 10.26355/eurrev_202305_32342.
8
In vitro and in vivo antibiofilm activity of the synthetic antimicrobial peptide WLBU2 against multiple drug resistant Pseudomonas aeruginosa strains.体外和体内抗多药耐药铜绿假单胞菌合成抗菌肽 WLBU2 的生物膜活性。
BMC Microbiol. 2023 May 15;23(1):131. doi: 10.1186/s12866-023-02886-x.
9
BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study.BL02,一种针对耐碳青霉烯类和多黏菌素 B 的肺炎克雷伯菌的噬菌体,从污水中分离:一项临床前研究。
Virus Res. 2023 Jul 2;331:199126. doi: 10.1016/j.virusres.2023.199126. Epub 2023 Apr 29.
10
Intelligent De Novo Design of Novel Antimicrobial Peptides against Antibiotic-Resistant Bacteria Strains.智能从头设计新型抗菌肽对抗抗生素耐药菌。
Int J Mol Sci. 2023 Apr 5;24(7):6788. doi: 10.3390/ijms24076788.